The Antibacterial Comparison of 5% and 2.5% Povidone Iodine to 0.01% Hypochlorous Acid Using Corneoscleral Tissue as a Solid-Phase Medium

Regis Kowalski,1 Roheena Kamyar,1 Michelle Rhee,2 Alex Mammen,1 Deepinder Dhaliwal,1 Eric G Romanowski,1 Vishal Jhanji,1 Andrew W Eller1 1University of Pittsburgh Medical Center (UPMC), The Charles T. Campbell Ophthalmic Microbiology Laboratory, Department of Ophthalmology, University of Pittsburgh...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kowalski R, Kamyar R, Rhee M, Mammen A, Dhaliwal D, Romanowski EG, Jhanji V, Eller AW
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/13f87917a79f40cb901550b2ce1246c1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:13f87917a79f40cb901550b2ce1246c1
record_format dspace
spelling oai:doaj.org-article:13f87917a79f40cb901550b2ce1246c12021-12-02T19:02:21ZThe Antibacterial Comparison of 5% and 2.5% Povidone Iodine to 0.01% Hypochlorous Acid Using Corneoscleral Tissue as a Solid-Phase Medium1177-5483https://doaj.org/article/13f87917a79f40cb901550b2ce1246c12021-09-01T00:00:00Zhttps://www.dovepress.com/the-antibacterial-comparison-of-5-and-25-povidone-iodine-to-001-hypoch-peer-reviewed-fulltext-article-OPTHhttps://doaj.org/toc/1177-5483Regis Kowalski,1 Roheena Kamyar,1 Michelle Rhee,2 Alex Mammen,1 Deepinder Dhaliwal,1 Eric G Romanowski,1 Vishal Jhanji,1 Andrew W Eller1 1University of Pittsburgh Medical Center (UPMC), The Charles T. Campbell Ophthalmic Microbiology Laboratory, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; 2The Eye-Bank for Sight Restoration, New York, NY, USACorrespondence: Regis KowalskiThe Charles T. Campbell Ophthalmic Microbiology Laboratory at the University of Pittsburgh School of Medicine, The Eye and Ear Institute, 203 Lothrop Street, Pittsburgh, Pa, 15213, USATel +1 412-647-7211Email kowalskirp@upmc.eduPurpose: Prophylactic topical antiseptics used to eliminate bacteria on the ocular surface prior to ocular surgery should be both effective and non-irritating. Five percent povidone iodine (PI) is an accepted antiseptic used for prophylaxis. Dilute 2.5% PI and 0.01% hypochlorous acid (HOCl) may be more patient comfortable and equally effective. PI at 5% and 2.5% were compared to HOCl against a battery of bacterial endophthalmitis isolates using corneoscleral tissue as a solid-phase medium to determine antiseptic efficacy.Methods: Bacteria from 20 cases of endophthalmitis were tested for the elimination of growth against topical 5% PI, 2.5% PI, HOCl, and no antiseptic using donor corneoscleral tissue. The tissue was inoculated with 103 colony forming units of bacteria prior to a 3-minute contact time with the antiseptics, placed in liquid growth medium, and monitored for growth at three days. No growth indicated antiseptic treatment success. Differences were analyzed using Chi square (χ 2).Results: For 20 isolates, 5% PI was comparable to 2.5% PI for preventing bacteria growth (p=0.71), and both were more effective than HOCl (p=0.004). Estimated weighted comparison over a 27-year period indicated that for all bacterial groups, except Streptococcus viridans, 5% PI was equally effective to 2.5% PI for preventing bacterial growth (p=1.0). For Streptococcus viridans, 5% PI was more effective than 2.5% PI (p=0.0001). Both concentrations of PI were more effective than HOCl (p=0.00001).Conclusion: Five percent PI appears to be optimal as a prophylaxis prior to ocular surgery.Keywords: povidone iodine, hypochlorous acid, endophthalmitis prophylaxis, intravitreal injection, corneoscleral tissue, antiseptic susceptibilityKowalski RKamyar RRhee MMammen ADhaliwal DRomanowski EGJhanji VEller AWDove Medical Pressarticlepovidone iodinehypochlorous acidendophthalmitis prophylaxisintravitreal injectioncorneoscleral tissueantiseptic susceptibilityOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 15, Pp 3697-3704 (2021)
institution DOAJ
collection DOAJ
language EN
topic povidone iodine
hypochlorous acid
endophthalmitis prophylaxis
intravitreal injection
corneoscleral tissue
antiseptic susceptibility
Ophthalmology
RE1-994
spellingShingle povidone iodine
hypochlorous acid
endophthalmitis prophylaxis
intravitreal injection
corneoscleral tissue
antiseptic susceptibility
Ophthalmology
RE1-994
Kowalski R
Kamyar R
Rhee M
Mammen A
Dhaliwal D
Romanowski EG
Jhanji V
Eller AW
The Antibacterial Comparison of 5% and 2.5% Povidone Iodine to 0.01% Hypochlorous Acid Using Corneoscleral Tissue as a Solid-Phase Medium
description Regis Kowalski,1 Roheena Kamyar,1 Michelle Rhee,2 Alex Mammen,1 Deepinder Dhaliwal,1 Eric G Romanowski,1 Vishal Jhanji,1 Andrew W Eller1 1University of Pittsburgh Medical Center (UPMC), The Charles T. Campbell Ophthalmic Microbiology Laboratory, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; 2The Eye-Bank for Sight Restoration, New York, NY, USACorrespondence: Regis KowalskiThe Charles T. Campbell Ophthalmic Microbiology Laboratory at the University of Pittsburgh School of Medicine, The Eye and Ear Institute, 203 Lothrop Street, Pittsburgh, Pa, 15213, USATel +1 412-647-7211Email kowalskirp@upmc.eduPurpose: Prophylactic topical antiseptics used to eliminate bacteria on the ocular surface prior to ocular surgery should be both effective and non-irritating. Five percent povidone iodine (PI) is an accepted antiseptic used for prophylaxis. Dilute 2.5% PI and 0.01% hypochlorous acid (HOCl) may be more patient comfortable and equally effective. PI at 5% and 2.5% were compared to HOCl against a battery of bacterial endophthalmitis isolates using corneoscleral tissue as a solid-phase medium to determine antiseptic efficacy.Methods: Bacteria from 20 cases of endophthalmitis were tested for the elimination of growth against topical 5% PI, 2.5% PI, HOCl, and no antiseptic using donor corneoscleral tissue. The tissue was inoculated with 103 colony forming units of bacteria prior to a 3-minute contact time with the antiseptics, placed in liquid growth medium, and monitored for growth at three days. No growth indicated antiseptic treatment success. Differences were analyzed using Chi square (χ 2).Results: For 20 isolates, 5% PI was comparable to 2.5% PI for preventing bacteria growth (p=0.71), and both were more effective than HOCl (p=0.004). Estimated weighted comparison over a 27-year period indicated that for all bacterial groups, except Streptococcus viridans, 5% PI was equally effective to 2.5% PI for preventing bacterial growth (p=1.0). For Streptococcus viridans, 5% PI was more effective than 2.5% PI (p=0.0001). Both concentrations of PI were more effective than HOCl (p=0.00001).Conclusion: Five percent PI appears to be optimal as a prophylaxis prior to ocular surgery.Keywords: povidone iodine, hypochlorous acid, endophthalmitis prophylaxis, intravitreal injection, corneoscleral tissue, antiseptic susceptibility
format article
author Kowalski R
Kamyar R
Rhee M
Mammen A
Dhaliwal D
Romanowski EG
Jhanji V
Eller AW
author_facet Kowalski R
Kamyar R
Rhee M
Mammen A
Dhaliwal D
Romanowski EG
Jhanji V
Eller AW
author_sort Kowalski R
title The Antibacterial Comparison of 5% and 2.5% Povidone Iodine to 0.01% Hypochlorous Acid Using Corneoscleral Tissue as a Solid-Phase Medium
title_short The Antibacterial Comparison of 5% and 2.5% Povidone Iodine to 0.01% Hypochlorous Acid Using Corneoscleral Tissue as a Solid-Phase Medium
title_full The Antibacterial Comparison of 5% and 2.5% Povidone Iodine to 0.01% Hypochlorous Acid Using Corneoscleral Tissue as a Solid-Phase Medium
title_fullStr The Antibacterial Comparison of 5% and 2.5% Povidone Iodine to 0.01% Hypochlorous Acid Using Corneoscleral Tissue as a Solid-Phase Medium
title_full_unstemmed The Antibacterial Comparison of 5% and 2.5% Povidone Iodine to 0.01% Hypochlorous Acid Using Corneoscleral Tissue as a Solid-Phase Medium
title_sort antibacterial comparison of 5% and 2.5% povidone iodine to 0.01% hypochlorous acid using corneoscleral tissue as a solid-phase medium
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/13f87917a79f40cb901550b2ce1246c1
work_keys_str_mv AT kowalskir theantibacterialcomparisonof5and25povidoneiodineto001hypochlorousacidusingcorneoscleraltissueasasolidphasemedium
AT kamyarr theantibacterialcomparisonof5and25povidoneiodineto001hypochlorousacidusingcorneoscleraltissueasasolidphasemedium
AT rheem theantibacterialcomparisonof5and25povidoneiodineto001hypochlorousacidusingcorneoscleraltissueasasolidphasemedium
AT mammena theantibacterialcomparisonof5and25povidoneiodineto001hypochlorousacidusingcorneoscleraltissueasasolidphasemedium
AT dhaliwald theantibacterialcomparisonof5and25povidoneiodineto001hypochlorousacidusingcorneoscleraltissueasasolidphasemedium
AT romanowskieg theantibacterialcomparisonof5and25povidoneiodineto001hypochlorousacidusingcorneoscleraltissueasasolidphasemedium
AT jhanjiv theantibacterialcomparisonof5and25povidoneiodineto001hypochlorousacidusingcorneoscleraltissueasasolidphasemedium
AT elleraw theantibacterialcomparisonof5and25povidoneiodineto001hypochlorousacidusingcorneoscleraltissueasasolidphasemedium
AT kowalskir antibacterialcomparisonof5and25povidoneiodineto001hypochlorousacidusingcorneoscleraltissueasasolidphasemedium
AT kamyarr antibacterialcomparisonof5and25povidoneiodineto001hypochlorousacidusingcorneoscleraltissueasasolidphasemedium
AT rheem antibacterialcomparisonof5and25povidoneiodineto001hypochlorousacidusingcorneoscleraltissueasasolidphasemedium
AT mammena antibacterialcomparisonof5and25povidoneiodineto001hypochlorousacidusingcorneoscleraltissueasasolidphasemedium
AT dhaliwald antibacterialcomparisonof5and25povidoneiodineto001hypochlorousacidusingcorneoscleraltissueasasolidphasemedium
AT romanowskieg antibacterialcomparisonof5and25povidoneiodineto001hypochlorousacidusingcorneoscleraltissueasasolidphasemedium
AT jhanjiv antibacterialcomparisonof5and25povidoneiodineto001hypochlorousacidusingcorneoscleraltissueasasolidphasemedium
AT elleraw antibacterialcomparisonof5and25povidoneiodineto001hypochlorousacidusingcorneoscleraltissueasasolidphasemedium
_version_ 1718377249584971776